Data / Medical devices / Italy / DiaSorin Italia S.p.A.
DiaSorin Italia S.p.A.: FDA-registered device maker in SALUGGIA Vercelli, Italy, 28 510(k) clearances and 14 PMA approvals
DiaSorin Italia S.p.A. is registered with the FDA (registration 9610240) in SALUGGIA Vercelli, Italy. It lists 42 device types. The FDA files 28 510(k) clearances and 14 PMA approvals under its listings, the newest dated May 7, 2026. Registered through 2027. FDA data exported November 3, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 9610240
- FEI number
- 3002808212
- Address
- VIA CRESCENTINO, snc, SALUGGIA Vercelli, Italy, 13040
- Owner or operator
- DiaSorin Inc. (9051149)
- Roles
- Manufacturer, Specification developer
- First device listed
- March 15, 1979
- Registered through
- 2027
- Brand names listed
- ETI-AB-AUK-3, ETI-AB-AUK-3 Negative Control, ETI-AB-DELTAk2, ETI-AB-EBK PLUS, ETI-EBK PLUS, ETI-MAX 3000 (TM) Analyzer Operating Software, ETI-MAX 3000TM Analyzer, HUMAN GROWTH HORMONE and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| December 23, 2025 | DEN250032 | LIAISON® XL MUREX Anti-HDV (318260); LIAISON® XL MUREX Control Anti-HDV (318261) | SGW | Unknown | DiaSorin, Inc. | accessdata.fda.gov |
| October 27, 2023 | K231214 | LIAISON VZV IgG HT, LIAISON Control VZV IgG HT | LFY | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| September 14, 2021 | K193650 | LIAISON Ferritin | DBF | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| March 2, 2020 | K193532 | LIAISON Anti-HAV Assay | LOL | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| February 27, 2018 | K173683 | LIAISON BRAHMS PCT II GEN, LIAISON Control BRAHMS PCT II GEN, LIAISON BRAHMS PCT II GEN Verifiers | PRI | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| January 6, 2017 | K162969 | LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set | LFZ | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| January 5, 2017 | K162961 | LIAISON® VCA IgG and LIAISON® VCA IgG Serum Control Set; LIAISON® EBNA IgG and LIAISON® EBNA IgG Serum Control Set | LSE | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| January 4, 2017 | K162959 | LIAISON® EA IgG and LIAISON® EA IgG Serum Control Set | LSE | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| August 25, 2016 | K160650 | LIAISON HAV IgM, LIAISON Control HAV IgM | LOL | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| June 30, 2016 | K161526 | LIAISON CMV IgM Serum Control Set | JJX | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| June 30, 2016 | K161522 | LIAISON EBV IgM Serum Control Set | JJX | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| July 25, 2014 | K141116 | LIAISON XL ANALYZER | LOL | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| September 6, 2013 | K131037 | LIAISON XL HCG | DHA | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| August 28, 2013 | K132234 | LIAISON(R) TOXO IGG II, LIAISON(R) CONTROL TOXO IGG II | LGD | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| August 9, 2013 | K131441 | LIAISON TOXO IGM II, LIAISON CONTROL TOXO IGM II | LGD | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| April 5, 2013 | K130469 | LIAISON TSH, LIAISON CONTROL THYROID 1, LIAISON CONTROL THYROID 2, LIAISON CONTROL THYROID 3 | JLW | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| April 4, 2013 | K121951 | LIAISON FT4 LIAISON CONTROL THYROID 1 LIAISON CONTROL THYROID 2 LIAISON CONTROL THYROID 3 | CEC | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| January 1, 2013 | K121944 | LIAISON DIRECT RENIN LIAISON CONTROL DIRECT RENIN LIAISON ENDOCRINOLOGY DILUENT | CIB | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| September 6, 2012 | K122397 | LIAISON RUBELLA IGM, LIAISON CONTROL RUBELLA IGM | LFX | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| January 21, 2011 | K103529 | LIAISON XL ANALYZER MODEL 10050 | LOL | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| October 29, 2010 | K102314 | 3M INTEGRATED CYCLER (110V) & (220V) | OOI | Substantially Equivalent | Focus Diagnostics, Inc. | accessdata.fda.gov |
| December 5, 2008 | K082049 | LIAISON ANTI-HAV ASSAY, LIAISON CONTROL ANTI-HAV | LOL | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| November 21, 2008 | K073390 | DIASORIN LIASON RUBELLA IGG ASSAY; DIASORIN LIAISON RUBELLA IGG TRI-CONTROLS | LFX | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| October 18, 2006 | K060204 | LIAISON EA IGG | LSE | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| July 31, 2006 | K061247 | DIASORIN LIAISON TREPONEMA ASSAY | LIP | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| March 31, 2006 | K052794 | ETI-MAX 3000 | JJF | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
| June 1, 2005 | K040290 | DIASORIN LIAISON CMV IGM/IGG | LFZ | Substantially Equivalent | Diasorin S.P.A | accessdata.fda.gov |
| April 29, 2005 | K040120 | DIASORIN LIAISON EBNA IGG, LIAISON VCA IGG, LIAISON VCA IGM ASSAYS | LLM | Substantially Equivalent | DiaSorin, Inc. | accessdata.fda.gov |
PMA approvals
Premarket approvals this establishment lists, with the supplements the FDA has decided since.
| Approved | PMA number | Device | Product code | Supplements | Latest decision | Source |
|---|---|---|---|---|---|---|
| May 7, 2026 | P250039 | LIAISON Biotrin Parvovirus B19 IgM Plus, LIAISON Biotrin Control Parvovirus B19 IgM Plus | MYM | 1 | June 24, 2026 | accessdata.fda.gov |
| March 29, 2024 | P220034 | LIAISON Biotrin Parvovirus B19 IgG Plus, LIAISON Biotrin Control Parvovirus B19 IgG Plus | MYL | 10 | August 18, 2026 | accessdata.fda.gov |
| August 29, 2020 | P190017 | LIAISON® XL MUREX HBsAg Qual, LIAISON® MUREX Control HBsAg, and LIAISON® XL MUREX HBsAg Confirmatory Test | LOM | 25 | October 10, 2025 | accessdata.fda.gov |
| August 29, 2020 | P180049 | LIAISON® XL MUREX anti-HBe, LIAISON® XL MUREX Control anti-HBe | SEI | 19 | October 10, 2025 | accessdata.fda.gov |
| August 29, 2020 | P180048 | LIAISON® XL MUREX HBeAg, LIAISON® XL MUREX Control HBeAg | LOM | 19 | October 10, 2025 | accessdata.fda.gov |
| August 29, 2020 | P180045 | LIAISON® XL MUREX HBc IgM, LIAISON® XL MUREX Control HBc IgM | SEI | 19 | October 10, 2025 | accessdata.fda.gov |
| February 21, 2020 | P180039 | LIAISON® XL MUREX Anti-HBs, LIAISON® XL MUREX Control Anti-HBs and LIAISON® XL MUREX Anti-HBs Verifiers | SEI | 21 | October 10, 2025 | accessdata.fda.gov |
| January 2, 2020 | P180038 | LIAISON XL MUREX Anti-HBc, LIAISON MUREX Control Anti-HBc | SEI | 26 | October 10, 2025 | accessdata.fda.gov |
| November 26, 2019 | P180047 | LIAISON QuantiFERON - TB Gold Plus, LIAISON Control QuantiFERON - TB Gold Plus and LIAISON QuantiFERON Software | NCD | 42 | September 24, 2026 | accessdata.fda.gov |
| October 18, 2019 | P190011 | LIAISON XL MUREX HCV Ab; LIAISON XL MUREX Control HCV Ab | MZO | 3 | August 10, 2021 | accessdata.fda.gov |
| March 30, 2001 | P990041 | DIASORIN ETI-AB-EBK PLUS ASSAY | 28 | December 21, 2021 | accessdata.fda.gov | |
| February 8, 2001 | P990043 | DIASORIN ETI-EBK PLUS ASSAY | LOM | 28 | December 21, 2021 | accessdata.fda.gov |
| August 6, 1999 | P970055 | BIOTRIN PARVOVIRUS IGM EIA (V619IMUS) | MYM | 21 | January 6, 2025 | accessdata.fda.gov |
| August 6, 1999 | P970054 | BIOTRIN PARVOVIRUS B19 IGG | MYL | 18 | January 6, 2025 | accessdata.fda.gov |
Compare with other makers
- All makers of Epstein-Barr Virus, Other
- All makers of Test, Antigen, Nuclear, Epstein-Barr Virus
- All makers of Single (Specified) Analyte Controls (Assayed And Unassayed)
- All makers of Radioimmunoassay, C-Peptides Of Proinsulin
- All makers of Radioimmunoassay, Human Growth Hormone
- All makers of Enzyme Linked Immunoabsorbent Assay, Varicella-Zoster
Updated June 24, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.